CD52 expression in T-cell large granular lymphocyte leukemia - Implications for treatment with alemtuzumab

Leukemia and Lymphoma

Volumn 46, Issue 5, 2005, Pages 723-727

  Osuji, N ^a   Del Giudice, I ^a   Matutes, E ^a   Morilla, A ^a   Owusu Ankomah, K ^a   Morilla, R ^a   Dunlop, A ^a   Catovsky, Daniel ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Alemtuzumab; CD52; Flow cytometry; LGL leukemia; T cell

Indexed keywords

ALEMTUZUMAB; CD52 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; B CELL LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LARGE GRANULAR LYMPHOCYTE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROLYMPHOCYTIC LEUKEMIA; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; T CELL LEUKEMIA;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTIGENS, CD; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; FLOW CYTOMETRY; GLYCOPROTEINS; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, LYMPHOCYTIC; LEUKEMIA, T-CELL;

EID: 20144385034     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190500052156     Document Type: Article

References (17)

1. Xia MQ, Hale G, Waldmann H. Efficient complement-mediated lysis of cells containing the CAMPATH-1 (CDw52) antigen. Mol Immunol 1993;30:1089-1096.
2. Xia MQ, Hale G, Lifely MR, Ferguson MA, Campbell D, Packman L, Waldmann H. Structure of the CAMPATH-1 antigen, a glycosylphosphatidylinositol-anchored glycoprotein which is an exceptionally good target for complement lysis. Biochem J 1993;293:633-640.
3. Dearden CE, Matutes E, Catovsky D. Alemtuzumab in T-cell malignancies. Med Oncol 2002;19(Suppl.):S27-S32.
4. Osuji N, Wotherspoon A, Catovsky D. Lessons from a case of T-cell large granular lymphocytic leukaemia suggesting that immunomodulatory therapy is more effective than intensive treatment. Leuk Res 2005;29:225-228.
5. Ru X, Liebman HA. Successful treatment of refractory pure red cell aplasia associated with lymphoproliferative disorders with the anti-CD52 monoclonal antibody alemtuzumab (Campath-1H). Br J Haematol 2003;123:278-281.
6. Rosenblum MD, LaBelle JL, Chang CC, Margolis DA, Schauer DW, Vesole DH. Efficacy of alemtuzumab treatment for refractory T-cell large granular lymphocytic leukemia. Blood 2004;103:1969-1971.
7. Ginaldi L, De Martinis M, Matutes E, Farahat N, Morilla R, Dyer MJ, Catovsky D. Levels of expression of CD52 in normal and leukemic B and T cells: correlation with in vivo therapeutic responses to Campath-1H. Leuk Res 1998;22:185-191.
8. Chan WC, Foucar K, Montserrat E. T-cell large granular lymphocyte leukaemia. In: Jaffe ES, Stein H, Vardiman JW, editors. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2001. p 197-198.
9. Matutes E, Catovsky D. Immunophenotyping. In: Lewis SM, Bates I, editors. Dacie and Lewis practical haematology, 9th edn. London: Churchill Livingstone; 2004. p 297-314.
10. Semenzato G, Zambello R, Starkebaum G, Oshimi K, Loughran TP Jr. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood 1997;89:256-260.
11. Altman D. Comparing groups - continuous data. Practical statistics for medical research, 1st edn. London: Chapman & Hall; 1991. p 179-228.
12. Lamy T, Loughran TP Jr. Current concepts: large granular lymphocyte leukemia. Blood Rev 1999;13:230-240.
13. Loughran TP Jr, Kidd PG, Starkebaum G. Treatment of large granular lymphocyte leukemia with oral low-dose methotrexate. Blood 1994;84:2164-2170.
14. Battiwalla M, Melenhorst J, Saunthararajah Y, Nakamura R, Molldrem J, Young NS, Barrett AJ. HLA-DR4 predicts haematological response to cyclosporine in T-large granular lymphocyte lymphoproliferative disorders. Br J Haematol 2003;123:449-453.
15. Sood R, Stewart CC, Aplan PD, Murai H, Ward P, Barcos M, Baer MR. Neutropenia associated with T-cell large granular lymphocyte leukemia: long-term response to cyclosporine therapy despite persistence of abnormal cells. Blood 1998;91:3372-3378.
16. Dearden CE, Matutes E, Cazin B, Tjonnfjord GE, Parreira A, Nomdedeu B, Leoni P, Clark FJ, Radia D, Rassam SM, et al. High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H. Blood 2001;98:1721-1726.
17. Loughran TP Jr. Clonal diseases of large granular lymphocytes. Blood 1993;82:1-14.